TRUQAP 200 mg/1

TRUQAP 200 mg is a film-coated tablet containing capivasertib, used for targeted therapy. This medication is designed to interact with specific proteins in the body, supporting cancer treatment protocols.

TRUQAP 200 mg is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins involved in cell growth and division, which can help slow or stop the progression of cancer cells. Patients often wonder, 'What is TRUQAP used for?' This medication is typically prescribed as part of a broader treatment plan, including other therapies.

Common effects of TRUQAP 200 mg may include fatigue, nausea, and diarrhea. Some users also report changes in appetite or skin reactions. These effects can vary widely among individuals and are not experienced by everyone who takes the medication.

TRUQAP 200 mg should be handled with care, following the guidance of a healthcare professional. It is important to store the medication properly and to adhere to the prescribed dosage. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider.

TRUQAP 200 mg may interact with other medications, including those that affect the liver's ability to metabolize drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of TRUQAP.